Bangor, PA, United States
BioSpectra, Inc. recalls
1 recall recorded since 2018, most recently on 29 July 2026. 1 is listed as ongoing. Status and classification are as published by the FDA.
Recalls1
Ongoing (FDA)1
Terminated or completed0
Class I (FDA)0
Ongoing Class II Drugs
- Recall started
- 29 July 2026
- Reason
- Failed stability specifications
- Distribution
- CA
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0012-2027
- Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDC 64173-101-25
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.